![](/img/cover-not-exists.png)
PDB44 THE COST-EFFECTIVENESS OF SAXAGLIPTIN VERSUS SULFONYLUREA (SU) IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (T2DM) IN GERMANY
W Erhardt, K Bergenheim, R Townsend, J Puelles Fernandez de Troconiz, P McEwanVolume:
13
Year:
2010
Language:
english
DOI:
10.1016/s1098-3015(11)72102-7
File:
PDF, 97 KB
english, 2010